High-Level Expression of Angiogenic Factors Is Associated with Advanced Tumor Stage in Human Neuroblastomas

作者: Garrett M. Brodeur , Bruce P. Himelstein , Janet Kwiatkowski , Angelika Eggert , Huaqing Zhao

DOI:

关键词:

摘要: Angiogenesis is essential for tumor growth and metastasis depends on the production of angiogenic factors by cells. Neuroblastoma (NB) a common pediatric neural crest origin, which biologically clinically heterogeneous. Increased vascular index correlates with poor outcome NB. To determine contribute to NB angiogenesis thereby support progression, we examined expression eight [vascular endothelial factor (VEGF), VEGF-B, VEGF-C, basic fibroblast factor, angiopoietin (Ang)-1, Ang-2, transforming alpha, platelet-derived (PDGF)] semiquantitative RT-PCR in 37 primary tumors 22 cell lines. We also analyzed relationship between clinicopathological as well patient survival. All were expressed at various levels lines tumors, suggesting their involvement angiogenesis. The most correlated each other, synergy regulating process. Significantly higher VEGF, PDGF-A (P < 0.0001-0.026) found advanced-stage (stages 3 4) compared low-stage 1, 2, 4S). Expression was significantly associated survival = 0.04). redundancy suggests that inhibition VEGF bioactivity alone might not be sufficient approach antiangiogenic therapy human

参考文章(55)
V. Joukov, K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, E. Kukk, O. Saksela, N. Kalkkinen, K. Alitalo, A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. The EMBO Journal. ,vol. 15, pp. 290- 298 ,(1996) , 10.1002/J.1460-2075.1996.TB00359.X
Ayako Yukita, Hideo Suzuki, Shinichi Kondo, Makoto Asano, Tomoe Matsumoto, Inhibition of Tumor Growth and Metastasis by an Immunoneutralizing Monoclonal Antibody to Human Vascular Endothelial Growth Factor/Vascular Permeability Factor121 Cancer Research. ,vol. 55, pp. 5296- 5301 ,(1995)
E. Tischer, R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J.C. Fiddes, J.A. Abraham, The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. Journal of Biological Chemistry. ,vol. 266, pp. 11947- 11954 ,(1991) , 10.1016/S0021-9258(18)99049-6
Douglas Hanahan, Signaling Vascular Morphogenesis and Maintenance Science. ,vol. 277, pp. 48- 50 ,(1997) , 10.1126/SCIENCE.277.5322.48
Susan Fuggle, Roy Bicknell, David Cranston, Tim O'Brien, Adrian L. Harris, Different Angiogenic Pathways Characterize Superficial and Invasive Bladder Cancer Cancer Research. ,vol. 55, pp. 510- 513 ,(1995)
K.A. Houck, D.W. Leung, A.M. Rowland, J Winer, N Ferrara, Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. Journal of Biological Chemistry. ,vol. 267, pp. 26031- 26037 ,(1992) , 10.1016/S0021-9258(18)35712-0
Per Kogner, Giuseppe Raschellá, Carlo Dominici, Manuel A. Castello, Håkan Persson, Gisela Barbany, Coexpression of Messenger RNA for TRK Protooncogene and Low Affinity Nerve Growth Factor Receptor in Neuroblastoma with Favorable Prognosis Cancer Research. ,vol. 53, pp. 2044- 2050 ,(1993)
D Meitar, S E Crawford, A W Rademaker, S L Cohn, Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. Journal of Clinical Oncology. ,vol. 14, pp. 405- 414 ,(1996) , 10.1200/JCO.1996.14.2.405
Eleanor J. Manseau, Brygida Berse, Kathi Tognazzi, Donald R. Senger, Lawrence F. Brown, Harold F. Dvorak, Robert W. Jackman, Expression of Vascular Permeability Factor (Vascular Endothelial Growth Factor) and Its Receptors in Adenocarcinomas of the Gastrointestinal Tract Cancer Research. ,vol. 53, pp. 4727- 4735 ,(1993)